findmyKOL

Kathryn Fantasia, MD

Basic profile

Boston University

ORCIDNPI
RegionBoston, MA · NortheastSpecialtyEndocrinology, Diabetes & MetabolismFocusEndocrinology/Metabolic
Active KOLfindmyKOL typefindmyKOL type: our influence ranking, shown when you reveal the full profileLatest publication2026Online presenceNot yet checkedPaymentsNone reportedNIH fundingNot yet indexedWhy? →

Kathryn Fantasia is an Endocrinology/Metabolic physician affiliated with Boston University. OpenAlex indexes 39 publications with 265 citations (h-index 8).

Overview

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
39publications

Distinct works indexed by OpenAlex, matched via ORCID.

265citations

Total citations across indexed works.

8h-index

Hirsch index, productivity × impact (OpenAlex).

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

732 Harrison Ave, Fl 2
Preston Bldg
Boston, MA 021182309

Telephone

617-638-7470

Provider last certified this registry record 1 Feb 2024.

View the NPPES registry record

Medicare prescribing footprint (2024)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Metabolism & gastrointestinal

    79.8%
    GLP-1 receptor agonist31.9%
    Ozempic55%Trulicity39%Mounjaro7%
    Part D<11 patients
    Insulin Analog22%
    Lantus Solostar34%Novolog Flexpen16%Tresiba Flextouch U-10015%Humalog Kwikpen U-10010%Basaglar Kwikpen U-1008%Insulin Lispro Kwikpen U-1006%Tresiba Flextouch U-2006%Fiasp Flextouch6%
    Part D<11 patients

    + 6 more classes in this area

  • Cardiovascular

    14.3%
    Statin11.4%
    Atorvastatin Calcium78%Simvastatin11%Rosuvastatin Calcium11%
    Part D<11 patients
    Angiotensin receptor blocker (ARB)1.6%
    Losartan Potassium100%
    Part D<11 patients

    + 1 more class in this area

  • Hormonal (systemic)

    3.6%
    l-Thyroxine3.6%
    Levothyroxine Sodium100%
    Part D11 patients
Where care is delivered (Part B)100% facility · 0% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

Publications

Matched to this physician's OpenAlex author record; most-cited works shown first.

Similar KOLs

Other experts from the same institution or the same specialty.

A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”